Velarion Records
Free. Unsubscribe any time.

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

MADRIGAL PHARMACEUTICALS, INC. filed 28 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 8 reporting owners, covering 254 transactions and 419,630 shares. None carries the SEC's AFF10B5ONE flag; all 28 name a plan in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in MADRIGAL PHARMACEUTICALS, INC. 254

Adoption dates in MADRIGAL PHARMACEUTICALS, INC. 11

Results prints in MADRIGAL PHARMACEUTICALS, INC. 8

Trades before a print in MADRIGAL PHARMACEUTICALS, INC. 0

Interval to MADRIGAL PHARMACEUTICALS, INC.’s next reported results date

How the interval and sources are counted →

Adoption dates MADRIGAL PHARMACEUTICALS, INC. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on March 14, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.

The address of this record

MADRIGAL PHARMACEUTICALS, INC.’s insider trading plan record — 28 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001157601.